Stéphane Legastelois
Directeur/Membre du Conseil chez BIOCORP
Provenance du réseau au premier degré de Stéphane Legastelois
Entité | Type d'entité | Industrie | |
---|---|---|---|
11
| Public Company | Medical Specialties | 11 |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon.
9
| Private Company | Miscellaneous Commercial Services | 9 |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation.
7
| Holding Company | Medical Specialties | 7 |
Jalon Therapeutics
Jalon Therapeutics Pharmaceuticals: MajorHealth Technology Jalon Therapeutics is a French company that aims to develop innovative therapies to treat cancer by inactivating vital tumor signaling pathways. Jalon Therapeutics is based in Paris, France and manages an extensive candidate portfolio of drug candidates infused by its unique expertise in AAC-11 biology. The company leverages their deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. The company's lead candidate, JRT39, is the first-in-class drug developed for the treatment of hard-to-treat cancers. The company is building a drug discovery platform to develop other candidates derived from AAC-11 and AAC-11 partners for the treatment of cancer. Jalon Therapeutics raised a pre-seed in 2022, leveraged by non-dilutive and quasi-equity fundings from public institutions. The company's growth ambition is to raise a seed immediately followed by a series A to finance up to the clinical proof of concept of their lead candidate JRT39. The company was founded in 2021 by Jérôme Tiollier, Jean-Luc Poyet, Prof. Martine Bagot, Prof. Hervé Dombret, Jean-Christophe Rain, and Philippe Salphati. The CEO is David Loison.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Transcure Bioservices SAS
Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners.
2
| Subsidiary | Medical/Nursing Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stéphane Legastelois via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
University of Lyon | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Founder | |
TRANSGENE | Biotechnology | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
ELSALYS BIOTECH | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Director/Board Member Director/Board Member | ||
Transgene, Inc. | Director/Board Member Director/Board Member | ||
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | Medical Specialties | Chief Executive Officer Founder | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Université Blaise Pascal | College/University | Doctorate Degree Undergraduate Degree | |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | President Director/Board Member | |
Holding ISF Masseran Technologies | Director/Board Member | ||
Proviciel SA
Proviciel SA Packaged SoftwareTechnology Services Proviciel SA design and develops secure industrial web applications. Its PEPS enables user to do messaging and share files. The company was founded by Henri Binsztok on December 24, 2008 and is headquartered in Paris, France. | Packaged Software | Chairman | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree | |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Private Equity Investor | |
Université de Technologie de Compiègne | College/University | Undergraduate Degree | |
Lucane Pharma SA
Lucane Pharma SA Pharmaceuticals: MajorHealth Technology Lucane Pharma SA produces pharmaceutical products. It develops medicines for niche therapeutics areas. The company was founded by Pierre Mambrini and Pamela Lewis and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
GREENCELL
GREENCELL Food: Major DiversifiedConsumer Non-Durables Greencell is a contract development and manufacturing organization that specializes in microbial biotechnology for depollution solutions. Greencell is located in France. The French company is a leader in microbial ecology and expert in industrial fermentation. The private company produces microorganisms and transforms them into innovative ingredients for agronomy, environment, nutrition, and health. | Food: Major Diversified | Chief Executive Officer | |
NANOBIOTIX | Medical Specialties | Director/Board Member | |
GLOBAL BIOENERGIES | Chemicals: Specialty | Director/Board Member | |
Eligo Bioscience SA
Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Medical/Nursing Services | Director/Board Member | |
GreenTech, Inc.
GreenTech, Inc. Specialty StoresRetail Trade Part of Geosoft the Co. Ltd., GreenTech, Inc. is a wood furniture store. The company is based in South Strafford, VT. GreenTech was acquired by Geosoft the Co. Ltd. on March 27, 1996. | Specialty Stores | Chairman | |
Gt Pharma | Chairman | ||
Greenmadag | Director/Board Member | ||
Emeraude SAS
Emeraude SAS MiscellaneousMiscellaneous Emeraude SAS provides general construction services. It offers energy renovation, facade treatment, cladding, thermal insulation, waterproofing, decoration and stone treatment services. The company was founded by Kamel Bouslama in 1995 and is headquartered in Tremblay-en-France, France. | Miscellaneous | Chairman | |
Greentech Brazil Ltda. | Chairman | ||
Allmicroalgae – Natural Products SA | Chief Executive Officer | ||
Mapric Produtos Farmacocosmeticos Ltd. | President | ||
BALYO | Industrial Machinery | Director/Board Member | |
Syndivia SAS
Syndivia SAS Pharmaceuticals: MajorHealth Technology Syndivia SAS engages in the development of treatment for cancer. Its product pipeline include SDV1001, for pancreatic cancer, colorectal cancer and TNBC; and SDV1101, for breast cancer and liposarcoma. The company is headquartered in Illkirch, France. | Pharmaceuticals: Major | Chairman | |
SkinJay SAS
SkinJay SAS Specialty StoresRetail Trade SkinJay SAS operates online store for oils, perfume and skin care products. The firm offer Pluie de Printemps, Draps de Brume, Pschht and Rosee Ravageuse. The company’s Skinjay mirror is a shower mixer and a unique collection of aromatic capsules, attached to the shower hose. The firm’s Skinjay mixer is based on a proprietary technology micro-nebulization. The company was founded by Nicolas Pasquier in 2012 and is headquartered in Paris, France. | Specialty Stores | Director/Board Member | |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member | |
Kreaxi SASU
Kreaxi SASU Investment ManagersFinance Kreaxi SASU (Kreaxi) is an independent private equity firm born from the merger of Rhône-Alpes Création and Banexi Ventures Partners. The company is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Baste SA
Baste SA Food: Specialty/CandyConsumer Non-Durables Baste SA wholesales bread, cakes and pastries. The company was founded in 1971 and is headquartered in Stosswihr, France. | Food: Specialty/Candy | Corporate Officer/Principal | |
Voxan-SCCM SA
Voxan-SCCM SA Auto Parts: OEMProducer Manufacturing Voxan-SCCM SA designs, manufactures, and markets touring motorcycles. Its product brands include Roadster, Cafe Racer, Scrambler, Street Scrambler, Black Magic, and Charade Racing. The company was founded in October 2002 and is headquartered in Issoire, France. | Auto Parts: OEM | Director of Finance/CFO | |
Aagie Sas | Chairman | ||
Groupement foncier agricole René PATOU | Corporate Officer/Principal | ||
Brenus Pharma SAS
Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Miscellaneous Commercial Services | Chief Executive Officer | |
ESSEC Business School | College/University | Masters Business Admin | |
Université d'Auvergne | College/University | Graduate Degree | |
Agence Française de Sécurité Sanitaire des Produits de Santé | Corporate Officer/Principal | ||
SNOWPACK
SNOWPACK Information Technology ServicesTechnology Services Snowpack is a European spin-off from CEA List that provides a next-generation network security solution. The private company is based in Europe and offers DarkSnow and RedSnow plans for accessing the dark web and performing tests live from anywhere in the world. The French company combines privacy and security on the internet through a unique overlay network that ensures complete invisibility. Snowpack's network overlay is defined as an "Ethical, Verifiable and No-trust Tor-like Overlay Network with unmatched Security and Performance". Standard terms apply, and illegal use is not allowed. | Information Technology Services | Chief Executive Officer | |
French Healthcare Consulting, Inc. | Founder | ||
Egle Therapeutics SAS
Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer | |
H-Immune SAS
H-Immune SAS Pharmaceuticals: MajorHealth Technology H-Immune SAS engages in biotechnology research activities. It develops medicine and pharmaceutical products. The company was founded on October 17, 2016 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman |
Statistiques
Internationale
France | 42 |
Etats-Unis | 4 |
Chine | 3 |
Brésil | 3 |
Madagascar | 2 |
Sectorielle
Health Technology | 13 |
Consumer Services | 7 |
Commercial Services | 5 |
Finance | 4 |
Consumer Non-Durables | 4 |
Opérationnelle
Director/Board Member | 65 |
Corporate Officer/Principal | 29 |
Chairman | 27 |
Chief Executive Officer | 22 |
Founder | 19 |
Relations les plus connectées
Insiders | |
---|---|
Philippe Archinard | 24 |
Stéphane Boissel | 24 |
Jean-Yves Berthon | 19 |
Marc Le Bozec | 16 |
Sébastien Groyer | 15 |
Jean-Yves Bonnefoy | 8 |
Luc Boblet | 8 |
Eric Dessertenne | 6 |
Marc Eloit | 5 |
Olivier Tillement | 3 |
Stéphane Chabanais | 3 |
Sandra Dubos | 3 |
Jérôme Tiollier | 3 |
Patrick Nef | 2 |
Emilie Gardette | 2 |
- Bourse
- Insiders
- Stéphane Legastelois
- Connexions Sociétés